<DOC>
	<DOC>NCT02052895</DOC>
	<brief_summary>This is an observational study to evaluate the diagnostic accuracy of presepsin levels to discriminate between sepsis and SIRS upon presentation with critical illness compatible with either sepsis or systemic inflammatory response syndrome (SIRS).</brief_summary>
	<brief_title>Utility of Presepsin in Distinguishing Between Sepsis and SIRS</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
	<criteria>Sepsis/SIRS Patients Male or female aged ≥ 21 years Appropriate clinical data to enable classification into sepsis or SIRS Written informed consent by the patient or legally authorized representative Critical illness consistent with SIRS or sepsis, to be enrolled within 18 hours of presentation No informed consent Unacceptable risk imposed by extra blood sampling, such as by gross hemorrhage with a hematocrit &lt; 20% Control Male or female aged ≥ 21 years Does not meet clinical criteria for sepsis or SIRS Written informed consent by the patient or legally authorized representative No informed consent Unacceptable risk imposed by extra blood sampling, such as by gross hemorrhage with a hematocrit &lt; 20% End Stage Renal Disease Male or female aged ≥ 21 years Documented diagnosis of end stage renal disease currently undergoing dialysis Does not meet clinical criteria for sepsis or SIRS Written informed consent by the patient or legally authorized representative No informed consent Unacceptable risk imposed by extra blood sampling, such as by gross hemorrhage with a hematocrit &lt; 20%</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Presepsin</keyword>
	<keyword>Sepsis</keyword>
	<keyword>SIRS</keyword>
</DOC>